Nuvectra to Present at Two Upcoming Investor Conferences
May 17 2018 - 8:30AM
Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical
device company, announced today that Scott Drees, Chief Executive
Officer, and Walter Berger, Chief Operating Officer & Chief
Financial Officer, are scheduled to present at two upcoming
investor conferences in June 2018.
|
|
|
|
|
|
|
|
|
Event: |
|
Jefferies 2018 Global
Healthcare Conference |
|
|
|
Date: |
|
Tuesday, June 5,
2018 |
|
|
|
Time: |
|
10:30 a.m. ET |
|
|
|
Location: |
|
The Grand Hyatt, New
York |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Event: |
|
JMP Securities Life
Sciences Conference |
|
|
|
Date: |
|
Wednesday, June 20,
2018 |
|
|
|
Time: |
|
2:30 p.m. ET |
|
|
|
Location: |
|
St. Regis Hotel, New
York |
|
|
|
|
|
|
A webcast of each presentation will be available
by visiting the investor relations section of Nuvectra’s website at
www.nuvectramed.com. A webcast replay of the presentation will be
available for 90 days.
Investors attending the conference who would like to schedule a
one-on-one meeting with Nuvectra management may do so by contacting
their Jefferies or JMP Securities representative, or Brian Johnston
of The Ruth Group at bjohnston@theruthgroup.com.
About Nuvectra Corporation
NuvectraTM is a neurostimulation company committed to helping
physicians improve the lives of people with chronic conditions. The
Algovita® Spinal Cord Stimulation (SCS) System is our first
commercial offering and is CE marked and FDA approved for the
treatment of chronic intractable pain of the trunk and/or limbs.
Our innovative technology platform also has capabilities under
development to support other indications such as sacral
neuromodulation (SNM) for the treatment of overactive bladder, and
deep brain stimulation (DBS) for the treatment of Parkinson’s
Disease. In addition, our NeuroNexus subsidiary designs,
manufactures and markets leading-edge neural-interface technologies
for the neuroscience clinical research market. Visit the Nuvectra
website at www.nuvectramed.com.
|
Company
Contacts: |
|
|
|
|
|
|
Investor
Contacts: |
Nuvectra
Corporation |
|
|
|
|
|
|
The Ruth
Group |
|
|
|
|
|
|
|
|
Walter Berger, COO
& CFO |
|
|
|
|
|
|
Tram Bui / Brian
Johnston |
(214) 474-3102 |
|
|
|
|
|
|
(646) 536-7035 /
7028 |
wberger@nuvectramed.com |
|
|
|
|
|
|
investors@nuvectramed.com |
Nuvectra (NASDAQ:NVTR)
Historical Stock Chart
From May 2024 to Jun 2024
Nuvectra (NASDAQ:NVTR)
Historical Stock Chart
From Jun 2023 to Jun 2024